Cargando…
A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months
BACKGROUND: VYC-17.5L (17.5 mg/mL hyaluronic acid, 0.3% lidocaine) is a dermal filler intended for deep dermis injection for the treatment of skin depressions. OBJECTIVE: To evaluate 12-month effectiveness and safety of VYC-17.5L for the treatment of moderate/severe nasolabial folds (NLFs). METHODS:...
Autores principales: | Sattler, Gerhard, Philipp-Dormston, Wolfgang G., Van Den Elzen, Helga, Van Der Walt, Cornelius, Nathan, Myooran, Kolodziejczyk, Julia, Kerson, Graeme, Dhillon, Benjeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414733/ https://www.ncbi.nlm.nih.gov/pubmed/28165349 http://dx.doi.org/10.1097/DSS.0000000000000939 |
Ejemplares similares
-
Safety and Effectiveness of the Hyaluronic Acid Dermal Filler VYC-17.5L for Nasolabial Folds: Results of a Randomized, Controlled Study
por: Monheit, Gary, et al.
Publicado: (2018) -
Juvéderm Volift (VYC-17.5L), a Hyaluronic Acid Filler with Lidocaine, is Safe and Effective for Correcting Nasolabial Folds in Chinese Subjects
por: Xie, Yun, et al.
Publicado: (2022) -
A Prospective, Open-Label, Multicenter, Real-World Study of VYC-17.5L Hyaluronic Acid Dermal Filler in the Lips
por: Demosthenous, Nestor, et al.
Publicado: (2022) -
A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips
por: Philipp-Dormston, Wolfgang G, et al.
Publicado: (2014) -
VYC-25L Hyaluronic Acid Injectable Gel Is Safe and Effective for Long-Term Restoration and Creation of Volume of the Lower Face
por: Ogilvie, Patricia, et al.
Publicado: (2020)